+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prostate Specific Antigen Test"

Prostate Specific Antigen (PSA) Test Market Report 2025 - Product Thumbnail Image

Prostate Specific Antigen (PSA) Test Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
2024 Global PSA Testing Market: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities - Product Thumbnail Image

2024 Global PSA Testing Market: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities

  • Report
  • August 2024
  • 249 Pages
  • Global, Europe, United States, ... Global, Europe, United States, Japan
From
From
From
From
Prostate Cancer Diagnostics Market Report 2025 - Product Thumbnail Image

Prostate Cancer Diagnostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

The Prostate Specific Antigen (PSA) Test is a diagnostic tool used to detect the presence of prostate cancer in men. It measures the amount of PSA, a protein produced by the prostate gland, in the blood. Elevated levels of PSA may indicate the presence of prostate cancer, although other conditions such as benign prostatic hyperplasia can also cause elevated PSA levels. The PSA Test is typically used in conjunction with other tests such as digital rectal examination and biopsy to confirm a diagnosis of prostate cancer. The PSA Test market is a subset of the larger Diagnostics market, which includes a wide range of tests used to diagnose and monitor diseases. The Diagnostics market is highly competitive, with a variety of companies offering a range of products and services. Some companies in the Prostate Specific Antigen Test market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Quest Diagnostics. Show Less Read more